<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
<channel>
<title>Yahoo! News: Business - Pharmaceutical</title>
<copyright>Copyright (c) 2008 Yahoo! Inc. All rights reserved.</copyright>
<link>http://news.yahoo.com/i/1190</link>
<description>Business - Pharmaceutical</description>
<language>en-us</language> 
<lastBuildDate>Fri, 04 Jul 2008 02:52:56 GMT</lastBuildDate>
<ttl>5</ttl> 
<image>
<title>Yahoo! News</title>
<width>142</width>
<height>18</height>
<link>http://news.yahoo.com/i/1190</link>
<url>http://us.i1.yimg.com/us.yimg.com/i/us/nws/th/main_142b.gif</url>
</image>
<item>
<title>Judge urges Eli Lilly to settle Zyprexa lawsuit 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080704/ap_on_bi_ge/lilly_zyprexa</link>
 <guid isPermaLink="false">ap/20080704/lilly_zyprexa</guid>
<source>AP</source>
<pubDate>Fri, 04 Jul 2008 02:52:56 GMT</pubDate>
<description>AP - A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug Zyprexa and exaggerated its usefulness.</description>
</item>
<item>
<title>2 drug firms to appeal &#36;114M price fraud verdict 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080703/ap_on_bi_ge/drug_suit</link>
 <guid isPermaLink="false">ap/20080703/drug_suit</guid>
<source>AP</source>
<pubDate>Thu, 03 Jul 2008 22:26:03 GMT</pubDate>
<description>AP - Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than &#36;114 million for overcharging the state&#039;s Medicaid program for prescription drugs.</description>
</item>
<item>
<title>&#39;Containers&#39; Out Perform Virtualization For KV Pharmaceuticals 
    (TechWeb)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/cmp/20080704/tc_cmp/208802705</link>
 <guid isPermaLink="false">cmp/20080704/208802705</guid>
<source>TechWeb</source>
<pubDate>Thu, 03 Jul 2008 21:00:00 GMT</pubDate>
<description>TechWeb - &lt;a href=&quot;http://us.rd.yahoo.com/dailynews/cmp/tc_cmp/storytext/208802705/28117104/SIG=131vslsa9/*http://www.informationweek.com/;jsessionid=MERCOZVDHPZG0QSNDLRCKHSCJUNN2JVN?cid=feed-yahoo-news&quot;&gt;InformationWeek&lt;/a&gt; - With a container approach from Parallels&#39; Virtuozzo, memory consumption and processor overhead are reduced through the use of one operating system per host.</description>
</item>
<item>
<title>Astra shares up 6 pct on Seroquel court ruling 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080702/ap_on_bi_ge/britain_astrazeneca</link>
 <guid isPermaLink="false">ap/20080702/britain_astrazeneca</guid>
<source>AP</source>
<pubDate>Wed, 02 Jul 2008 11:45:00 GMT</pubDate>
<description>AP - Shares in AstraZeneca PLC jumped 6 percent Wednesday after the drug maker won a key patent battle in the United States over Seroquel, its anti-psychotic drug and second-best seller.</description>
</item>
<item>
<title>SureScripts, RxHub Merge To Expand E-Prescribing Network 
    (TechWeb)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/cmp/20080702/tc_cmp/208801933</link>
 <guid isPermaLink="false">cmp/20080702/208801933</guid>
<source>TechWeb</source>
<pubDate>Tue, 01 Jul 2008 18:20:00 GMT</pubDate>
<description>TechWeb - &lt;a href=&quot;http://us.rd.yahoo.com/dailynews/cmp/tc_cmp/storytext/208801933/28091029/SIG=131r5i6vp/*http://www.informationweek.com/;jsessionid=KY15S3HCWSY0YQSNDLQCKHSCJUNN2JVN?cid=feed-yahoo-news&quot;&gt;InformationWeek&lt;/a&gt; - The combination will form a single secure national network for the exchange of prescription related data between physicians, pharmacies, and prescription benefit management organizations.</description>
</item>
<item>
<title>Drug chains and benefits managers team on e-prescriptions 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080701/bs_nm/electronic_prescribing_dc</link>
 <guid isPermaLink="false">nm/20080701/electronic_prescribing_dc</guid>
<source>Reuters</source>
<pubDate>Tue, 01 Jul 2008 14:47:37 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080701/bs_nm/electronic_prescribing_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080701/2008_07_01t104638_450x322_us_electronic_prescribing.jpg?x=130&amp;y=93&amp;q=85&amp;sig=OIz1MEzrie9aJcorTQTjUQ--" align="left" height="93" width="130" alt="A pharmacist works at a pharmacy in Toronto, January 31, 2008. (Mark Blinch/Reuters)" border="0" />&#60;/a>Reuters - Chain drug stores including 
Walgreens  and pharmacy benefits managers like Medco 
Health Solutions  are combining their electronic 
networks to speed adoption of computerized prescriptions.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/nm/20080701/2008_07_01t104638_450x322_us_electronic_prescribing.jpg?x=130&amp;y=93&amp;q=85&amp;sig=OIz1MEzrie9aJcorTQTjUQ--" type="image/jpeg" height="93" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080701/bs_nm/electronic_prescribing_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080701/2008_07_01t104638_450x322_us_electronic_prescribing.jpg?x=130&amp;y=93&amp;q=85&amp;sig=OIz1MEzrie9aJcorTQTjUQ--" align="left" height="93" width="130" alt="photo" title="A pharmacist works at a pharmacy in Toronto, January 31, 2008. (Mark Blinch/Reuters)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(Reuters)</media:credit>
</item>
<item>
<title>Medication managers, drug stores merge networks 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080701/ap_on_bi_ge/electronic_prescribing_merger</link>
 <guid isPermaLink="false">ap/20080701/electronic_prescribing_merger</guid>
<source>AP</source>
<pubDate>Tue, 01 Jul 2008 04:15:12 GMT</pubDate>
<description>AP - The drug store and pharmacy benefit management industries on Tuesday will announce a combination of their information systems in order to boost electronic prescribing by physicians.</description>
</item>
<item>
<title>Lilly agrees to settle discrimination lawsuit 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080701/ap_on_bi_ge/lilly_discrimination_settlement</link>
 <guid isPermaLink="false">ap/20080701/lilly_discrimination_settlement</guid>
<source>AP</source>
<pubDate>Tue, 01 Jul 2008 02:33:28 GMT</pubDate>
<description>AP - Drug maker Eli Lilly and Co. will pay &#36;64,400 to settle a lawsuit accusing the company of withholding severance pay to force a longtime employee to withdraw a discrimination charge.</description>
</item>
<item>
<title>Kmart expands generic drug program 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080630/us_nm/kmart_dc</link>
 <guid isPermaLink="false">nm/20080630/kmart_dc</guid>
<source>Reuters</source>
<pubDate>Mon, 30 Jun 2008 20:03:52 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080630/us_nm/kmart_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080630/2008_06_30t152313_348x450_us_kmart.jpg?x=100&amp;y=130&amp;q=85&amp;sig=CrxGZrlR.3pQPnARtr_6KA--" align="left" height="130" width="100" alt="A Kmart store in Round Lake Beach, Illinois, is seen in this November 17, 2004 file photo. (John Gress/Reuters)" border="0" />&#60;/a>Reuters - Retailer Kmart said on Monday it has 
expanded its generic prescription drug program to include more 
than 500 common medications from about 300 and cut prices for 
some products as of June 22.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/nm/20080630/2008_06_30t152313_348x450_us_kmart.jpg?x=100&amp;y=130&amp;q=85&amp;sig=CrxGZrlR.3pQPnARtr_6KA--" type="image/jpeg" height="130" width="100"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080630/us_nm/kmart_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080630/2008_06_30t152313_348x450_us_kmart.jpg?x=100&amp;y=130&amp;q=85&amp;sig=CrxGZrlR.3pQPnARtr_6KA--" align="left" height="130" width="100" alt="photo" title="A Kmart store in Round Lake Beach, Illinois, is seen in this November 17, 2004 file photo. (John Gress/Reuters)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(Reuters)</media:credit>
</item>
<item>
<title>Accidental fungus leads to promising cancer drug 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080629/sc_nm/cancer_nanoparticles_dc</link>
 <guid isPermaLink="false">nm/20080629/cancer_nanoparticles_dc</guid>
<source>Reuters</source>
<pubDate>Sun, 29 Jun 2008 22:28:55 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080629/sc_nm/cancer_nanoparticles_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080630/2008_06_30t111517_450x438_us_cancer_nanoparticles.jpg?x=130&amp;y=126&amp;q=85&amp;sig=ZizdTCZ3THlp4ujg35s69Q--" align="left" height="126" width="130" alt="A Lodamin nanoparticle with TNP-470 (the drug&#039;s active ingredient) at the core, protected by two short polymers (PEG and PLA) that allow TNP-470 to be absorbed intact when taken orally is seen in an undated handout illustration. (Children&#039;s Hospital Boston/Handout/Reuters)" border="0" />&#60;/a>Reuters - A drug developed using 
nanotechnology and a fungus that contaminated a lab experiment 
may be broadly effective against a range of cancers, U.S. 
researchers reported on Sunday.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/nm/20080630/2008_06_30t111517_450x438_us_cancer_nanoparticles.jpg?x=130&amp;y=126&amp;q=85&amp;sig=ZizdTCZ3THlp4ujg35s69Q--" type="image/jpeg" height="126" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080629/sc_nm/cancer_nanoparticles_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080630/2008_06_30t111517_450x438_us_cancer_nanoparticles.jpg?x=130&amp;y=126&amp;q=85&amp;sig=ZizdTCZ3THlp4ujg35s69Q--" align="left" height="126" width="130" alt="photo" title="A Lodamin nanoparticle with TNP-470 (the drug&#039;s active ingredient) at the core, protected by two short polymers (PEG and PLA) that allow TNP-470 to be absorbed intact when taken orally is seen in an undated handout illustration. (Children&#039;s Hospital Boston/Handout/Reuters)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(Reuters)</media:credit>
</item>
<item>
<title>Rite Aid posts 1Q loss amid acquisition expenses 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080626/ap_on_bi_ge/earns_rite_aid</link>
 <guid isPermaLink="false">ap/20080626/earns_rite_aid</guid>
<source>AP</source>
<pubDate>Thu, 26 Jun 2008 21:28:48 GMT</pubDate>
<description>AP - Rite Aid Corp. swung to a big first-quarter loss as it spent heavily to absorb more than 1,850 newly acquired stores and offered promotions on food and toiletries that hurt profits.</description>
</item>
<item>
<title>Plastics expert wins &#36;500K Lemelson-MIT award 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080625/ap_on_sc/lemelson_mit_award</link>
 <guid isPermaLink="false">ap/20080625/lemelson_mit_award</guid>
<source>AP</source>
<pubDate>Wed, 25 Jun 2008 04:05:45 GMT</pubDate>
<description>AP - Consumers have environmentally friendlier plastics, patients in clinical trials have a new device to treat clogged arteries and we all might get disease-treating nanoparticles inside our bodies thanks in part to the work of one man, the winner of this year&#039;s Lemelson-MIT Prize.</description>
</item>
<item>
<title>Bayer and Barr agree oral contraceptive deal 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080624/bs_nm/barr_bayer_dc</link>
 <guid isPermaLink="false">nm/20080624/barr_bayer_dc</guid>
<source>Reuters</source>
<pubDate>Tue, 24 Jun 2008 09:28:30 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080624/bs_nm/barr_bayer_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080624/2008_06_24t043546_323x450_us_barr_bayer.jpg?x=93&amp;y=130&amp;q=85&amp;sig=TvbhtShYURlZkqWmUlwDtw--" align="left" height="130" width="93" alt="The Bayer AG logo is seeing at a house during the company annual news conference in Leverkusen, March 15, 2005. (Kirsten Neumann/Reuters)" border="0" />&#60;/a>Reuters - Germany&#39;s Bayer AG  agreed 
to supply a generic version of its Yasmin oral contraceptive 
for Barr Pharmaceuticals Inc  to market in the United 
States in return for a fixed portion of sales.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/nm/20080624/2008_06_24t043546_323x450_us_barr_bayer.jpg?x=93&amp;y=130&amp;q=85&amp;sig=TvbhtShYURlZkqWmUlwDtw--" type="image/jpeg" height="130" width="93"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080624/bs_nm/barr_bayer_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080624/2008_06_24t043546_323x450_us_barr_bayer.jpg?x=93&amp;y=130&amp;q=85&amp;sig=TvbhtShYURlZkqWmUlwDtw--" align="left" height="130" width="93" alt="photo" title="The Bayer AG logo is seeing at a house during the company annual news conference in Leverkusen, March 15, 2005. (Kirsten Neumann/Reuters)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(Reuters)</media:credit>
</item>
<item>
<title>Walgreen quarterly profit rises 2 percent 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080623/bs_nm/walgreen_dc</link>
 <guid isPermaLink="false">nm/20080623/walgreen_dc</guid>
<source>Reuters</source>
<pubDate>Mon, 23 Jun 2008 17:17:14 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080623/bs_nm/walgreen_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080702/2008_07_02t091837_450x248_us_walgreen.jpg?x=130&amp;y=71&amp;q=85&amp;sig=.ExO1Wv5LM5dBsZ9hpia2A--" align="left" height="71" width="130" alt="The sign at a Walgreens store is seen in Golden, Colorado, June 25, 2007. (Rick Wilking/Reuters)" border="0" />&#60;/a>Reuters - Walgreen Co  on Monday posted a 
2 percent increase in quarterly profit as a weak U.S. economy 
and slowing growth in demand for prescription drugs muted 
sales.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/nm/20080702/2008_07_02t091837_450x248_us_walgreen.jpg?x=130&amp;y=71&amp;q=85&amp;sig=.ExO1Wv5LM5dBsZ9hpia2A--" type="image/jpeg" height="71" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080623/bs_nm/walgreen_dc">&#60;img src="http://d.yimg.com/us.yimg.com/p/nm/20080702/2008_07_02t091837_450x248_us_walgreen.jpg?x=130&amp;y=71&amp;q=85&amp;sig=.ExO1Wv5LM5dBsZ9hpia2A--" align="left" height="71" width="130" alt="photo" title="The sign at a Walgreens store is seen in Golden, Colorado, June 25, 2007. (Rick Wilking/Reuters)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(Reuters)</media:credit>
</item>
<item>
<title>&quot;Virtual man&quot; may ease drug R&amp;D woes: report 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080619/sc_nm/pharmaceuticals_research_dc</link>
 <guid isPermaLink="false">nm/20080619/pharmaceuticals_research_dc</guid>
<source>Reuters</source>
<pubDate>Thu, 19 Jun 2008 23:09:30 GMT</pubDate>
<description>Reuters - New computing technologies and the 
evolution of a &quot;virtual man&quot; to predict the effects of new 
drugs before they enter clinical trials could transform the 
fortunes of pharmaceutical research, a report said on Friday.</description>
</item>
<item>
<title>Icahn loses campaign to change Biogen Idec board 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20080619/ap_on_bi_ge/biogen_idec_icahn</link>
 <guid isPermaLink="false">ap/20080619/biogen_idec_icahn</guid>
<source>AP</source>
<pubDate>Thu, 19 Jun 2008 18:34:19 GMT</pubDate>
<description>AP - Carl Icahn lost his campaign to elect a slate of dissident nominees to Biogen Idec Inc.&#039;s board on Thursday, an effort the activist investor hoped would eventually trigger a sale of the 30-year biotechnology firm to a major pharmaceutical company.</description>
</item>
<item>
<title>CORRECTED: Counterfeit, pirated goods costing U.S. billions 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080619/us_nm/usa_counterfeits_dc</link>
 <guid isPermaLink="false">nm/20080619/usa_counterfeits_dc</guid>
<source>Reuters</source>
<pubDate>Thu, 19 Jun 2008 00:13:03 GMT</pubDate>
<description>Reuters - Experts from the automotive, 
pharmaceutical, and product safety industries told a U.S. 
Senate panel on Tuesday that counterfeit and pirated goods cost 
the U.S. economy billions of dollars and jeopardize the safety 
of consumers.</description>
</item>
<item>
<title>Roche announces major investment in Swiss units 
    (AFP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20080617/bs_afp/switzerlandcompanypharmaroche</link>
 <guid isPermaLink="false">afp/20080617/switzerlandcompanypharmaroche</guid>
<source>AFP</source>
<pubDate>Tue, 17 Jun 2008 07:05:40 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20080617/bs_afp/switzerlandcompanypharmaroche">&#60;img src="http://d.yimg.com/us.yimg.com/p/afp/20080617/capt.cps.mta61.170608090519.photo00.photo.default-512x341.jpg?x=130&amp;y=86&amp;q=85&amp;sig=jFJY77A27tva0BQkT_yZ_g--" align="left" height="86" width="130" alt="The logo of Swiss pharmaceuticals giant Roche on a building in Basel. Roche has announced an investment of 1.2 billion Swiss Francs (US$743 million) in its production and research units in Switzerland(AFP/File/Fabrice Coffrini)" border="0" />&#60;/a>AFP - Swiss pharmaceutical giant Roche announced on Tuesday an investment of 1.2 billion Swiss Francs (743 million dollars) in its production and research units in Switzerland.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/afp/20080617/capt.cps.mta61.170608090519.photo00.photo.default-512x341.jpg?x=130&amp;y=86&amp;q=85&amp;sig=jFJY77A27tva0BQkT_yZ_g--" type="image/jpeg" height="86" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20080617/bs_afp/switzerlandcompanypharmaroche">&#60;img src="http://d.yimg.com/us.yimg.com/p/afp/20080617/capt.cps.mta61.170608090519.photo00.photo.default-512x341.jpg?x=130&amp;y=86&amp;q=85&amp;sig=jFJY77A27tva0BQkT_yZ_g--" align="left" height="86" width="130" alt="photo" title="The logo of Swiss pharmaceuticals giant Roche on a building in Basel. Roche has announced an investment of 1.2 billion Swiss Francs (US$743 million) in its production and research units in Switzerland(AFP/File/Fabrice Coffrini)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AFP)</media:credit>
</item>
<item>
<title>US FDA sees possible J&amp;J psoriasis drug risks 
    (Reuters)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20080613/us_nm/johnsonandjohnson_psoriasis_dc</link>
 <guid isPermaLink="false">nm/20080613/johnsonandjohnson_psoriasis_dc</guid>
<source>Reuters</source>
<pubDate>Fri, 13 Jun 2008 18:31:15 GMT</pubDate>
<description>Reuters - An experimental psoriasis drug from 
Johnson &amp; Johnson is effective at relieving symptoms but 
extended use may raise the risk of cancer, U.S. drug reviewers 
said in documents released on Friday.</description>
</item>
<item>
<title>Pfizer may counter Daiichi&#39;s Ranbaxy bid: report 
    (AFP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20080613/bs_afp/japanindiapharmacompanypfizertakeoverdaiichisankyo</link>
 <guid isPermaLink="false">afp/20080613/japanindiapharmacompanypfizertakeoverdaiichisankyo</guid>
<source>AFP</source>
<pubDate>Fri, 13 Jun 2008 06:43:57 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20080613/bs_afp/japanindiapharmacompanypfizertakeoverdaiichisankyo">&#60;img src="http://d.yimg.com/us.yimg.com/p/afp/20080613/capt.cps.msc12.130608083858.photo00.photo.default-512x341.jpg?x=130&amp;y=86&amp;q=85&amp;sig=7HqBX0OGRYwlkmqQMKN69g--" align="left" height="86" width="130" alt="A pharmacy in Mumbai. Pharmaceutical giant Pfizer may make a counter-offer for Indian firm Ranbaxy in an attempt to thwart a takeover bid by Japanese pharmaceutical firm Daiichi Sankyo, a report said(AFP/File/Indranil Mukherjee)" border="0" />&#60;/a>AFP - Pharmaceutical giant Pfizer may make a counter-offer for Indian firm Ranbaxy in an attempt to thwart a takeover bid by Japanese pharmaceutical firm Daiichi Sankyo, a report said Friday.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/us.yimg.com/p/afp/20080613/capt.cps.msc12.130608083858.photo00.photo.default-512x341.jpg?x=130&amp;y=86&amp;q=85&amp;sig=7HqBX0OGRYwlkmqQMKN69g--" type="image/jpeg" height="86" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20080613/bs_afp/japanindiapharmacompanypfizertakeoverdaiichisankyo">&#60;img src="http://d.yimg.com/us.yimg.com/p/afp/20080613/capt.cps.msc12.130608083858.photo00.photo.default-512x341.jpg?x=130&amp;y=86&amp;q=85&amp;sig=7HqBX0OGRYwlkmqQMKN69g--" align="left" height="86" width="130" alt="photo" title="A pharmacy in Mumbai. Pharmaceutical giant Pfizer may make a counter-offer for Indian firm Ranbaxy in an attempt to thwart a takeover bid by Japanese pharmaceutical firm Daiichi Sankyo, a report said(AFP/File/Indranil Mukherjee)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AFP)</media:credit>
</item>
</channel>
</rss>
<!-- server fe9.news.sp1.yahoo.com -->

<!-- fe9.news.sp1.yahoo.com compressed/chunked Fri Jul  4 06:09:11 PDT 2008 -->
